MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,778 Cr | ₹1,293 Cr | ₹1,110 Cr | ₹1,070 Cr | ₹858 Cr |
What is the latest Total Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,778 Cr |
| Mar2024 | ₹1,293 Cr |
| Mar2023 | ₹1,110 Cr |
| Mar2022 | ₹1,070 Cr |
| Mar2021 | ₹858 Cr |
How is Total Liabilities of MOREPEN LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,778 Cr | 37.50 | |
| Mar2024 | ₹1,293 Cr | 16.45 | |
| Mar2023 | ₹1,110 Cr | 3.78 | |
| Mar2022 | ₹1,070 Cr | 24.69 | |
| Mar2021 | ₹858 Cr | - | |
Compare Total Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹2,081.3 Cr | 2.7% | -13.3% | -21.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | 2.7% |
-13.3% |
-21.6% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses